Concepedia

Shreya Chablaney

SC

Statistics

Publications

7

Citations

253

H-Index

7

Active since

2018

Affiliations

Indiana University – Purdue University Indianapolis(Current)

University of California San Diego

Icahn School of Medicine at Mount Sinai

Dartmouth–Hitchcock Medical Center

Lenox Hill Hospital

Shreya Chablaney is an author at Indiana University – Purdue University Indianapolis specializing in pharmacotherapy, rheumatoid arthritis, and medicine.

ORCID

Top concepts

Publications per year

2018–2020

7

Publications

7

Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

Parambir S. Dulai, Siddharth Singh, Niels Vande Casteele et al. · Clinical Gastroenterology and Hepatology · 2020 · 76 citations · Full text

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis

David M. Faleck, Adam C. Winters, Shreya Chablaney et al. · Clinical Gastroenterology and Hepatology · 2019 · 67 citations · Full text

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

Dana J. Lukin, David M. Faleck, Ronghui Xu et al. · Clinical Gastroenterology and Hepatology · 2020 · 58 citations · Full text

Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes

Jenna L. Koliani‐Pace, Siddharth Singh, Michelle Luo et al. · Inflammatory Bowel Diseases · 2019 · 15 citations · Full text

OP026 Comparative effectiveness of vedolizumab and TNF-antagonist therapy in ulcerative colitis: a multicentre consortium propensity score-matched analysis

David M. Faleck, Preeti Shashi, Joseph Meserve et al. · Journal of Crohn s and Colitis · 2018 · 14 citations · Full text

, , +11

1–5 of 7